NovaBay Pharma (NBY) – Major News
-
NovaBay Pharma (NBY) Tops Q3 EPS by 4c
-
NovaBay Pharma (NBY) Misses Q1 EPS by 32c
-
NovaBay Pharma (NBY) Misses Q3 EPS by 7c
-
NovaBay Pharma (NBY) Tops Q4 EPS by 3c
-
NovaBay Pharma (NBY) Reports In-Line Q2 EPS
-
NovaBay Pharma (NBY) Reports In-Line Q4 EPS, Revenues Miss
-
NovaBay Pharma (NBY) Reports Q3 Loss of $0.08/sh
-
NovaBay Pharma (NBY) Misses Q4 EPS by 6c, Revenues Miss
-
NovaBay Pharma (NBY) Reports Q2 Revenues Above Consensus
-
NovaBay Pharma (NBY) Reports Q1 Loss of $0.28/Share
-
NovaBay Pharma (NBY) Reports Q3 Loss of $0.11, Revenues Miss
-
NovaBay Pharma (NBY) Tops Q2 EPS by 3c
-
NovaBay Pharma (NBY) Misses Q1 EPS by 6c
-
NovaBay Pharma (NBY) Tops Q4 EPS by 2c, Beats on Revenues
-
NovaBay Pharma (NBY) Misses Q3 EPS by 7c, Miss on Revenues; Lowers FY17 Revenue Outlook Below Consensus
-
NovaBay Pharma (NBY) Tops Q2 EPS by 1c
-
NovaBay Pharma (NBY) Misses Q1 EPS by 14c
-
NovaBay Pharma (NBY) Tops Q4 EPS by 18c
-
NovaBay Pharma (NBY) Misses Q3 EPS by 18c
-
NovaBay Pharma (NBY) Misses Q2 EPS by 6c
-
NovaBay Pharma (NBY) Misses Q1 EPS Views
-
NovaBay Pharma (NBY) Tops Q4 EPS by 10c
-
NovaBay Pharma (NBY) Reports In-Line Q3 EPS; Announces Corp. Restructuring, Names New CEO
-
NovaBay Pharma (NBY) Reports In-Line Q2 EPS
-
NovaBay Pharma (NBY) Announces Presentation of Positive Avenova Reserach in Blepharitis
-
NovaBay Pharma (NBY) Misses Q4 EPS by 2c
-
NovaBay Pharma (NBY) Tops Q3 EPS by 1c
-
NovaBay Pharmaceuticals (NBY) Posts Q1 Loss of 8c/Share
-
NovaBay (NBY) Stock Tanks; Phase 2b Auriclosene for Impetigo Doesn't Meet Endpoint
-
NovaBay Pharmaceuticals (NBY) Posts Q1 Loss of 11c/Share
-
NovaBay Pharmaceuticals (NBY) Posts Q4 Loss of 8c/Share
-
NovaBay Pharmaceuticals (NBY) Posts Break Even Q3 Loss
-
NovaBay Pharmaceuticals (NBY) Reports In-Line Q2 Loss of 8c/Share
-
NovaBay Pharmaceuticals (NBY) Swings to Q4 Loss on Lighter Revs
-
NovaBay Pharma (NBY) Posts Break Even Q3 EPS
-
NovaBay Pharmaceuticals (NBY) Posts Surprise Q2 Profit
-
NovaBay Pharma (NBY) Posts Wider than Expected Q1 Loss
-
NovaBay Pharma (NBY) Posts Wider Q3 Loss; Revs Light
-
NovaBay Pharma (NBY) Posts Q2 Loss of 5c, Beats Views
-
NovaBay Pharmaceuticals (NBY) Reports Smaller-Than-Expected Q1 Loss
-
NovaBay Pharma (NBY) Posts Q3 Break-Even EPS, 1c Better Than Estimates
Back to NBY Stock Lookup